|
|
|
|
|
ML Estimates of |
Follow-Up Period |
Treatment Arms |
Size |
Mean |
Variance |
 |
 |
Year 1 |
Control |
51 |
1.5294 |
1.3341 |
1.5294 |
-0.1344 |
|
s.c. IFN beta-1a |
46 |
0.3696 |
0.5048 |
0.3696 |
1.1538 |
|
i.m. IFN beta-1a |
46 |
1.1522 |
1.3319 |
1.1522 |
0.1420 |
|
GA |
48 |
0.7917 |
0.7642 |
0.7917 |
-0.0853 |
|
|
|
|
|
|
|
Year 2 |
Control |
51 |
2.9608 |
4.5584 |
2.9608 |
0.2559 |
|
s.c. IFN beta-1a |
46 |
0.7174 |
0.7850 |
0.7174 |
0.0818 |
|
i.m. IFN beta-1a |
47 |
1.6596 |
2.2294 |
1.6596 |
0.2326 |
|
GA |
48 |
1.2917 |
1.4876 |
1.2917 |
0.1225 |
|